These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6399108

  • 1. [Place and role of tissue plasminogen activator in the fibrinolysis process].
    Wilczyńska M, Cierniewski C.
    Postepy Hig Med Dosw; 1984; 38(4):481-97. PubMed ID: 6399108
    [No Abstract] [Full Text] [Related]

  • 2. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR, Soria J, Soria C, Collen D, Caen JP.
    Thromb Haemost; 1984 Feb 28; 51(1):108-9. PubMed ID: 6539000
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The vascular wall and fibrinolysis--pharmacologic aspects].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Feb 28; 113(1-2):164-75. PubMed ID: 2427397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The fibrinolytic system and its activators].
    Seifried E.
    Z Gesamte Inn Med; 1993 Feb 28; 48(6-7):272-82. PubMed ID: 8333223
    [Abstract] [Full Text] [Related]

  • 7. [Molecular mechanisms of blood coagulation and fibrinolysis activation].
    Worowski K.
    Postepy Hig Med Dosw; 1980 Feb 28; 34(3):189-233. PubMed ID: 6455654
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition.
    Norrman B, Wallén P, Rånby M.
    Eur J Biochem; 1985 May 15; 149(1):193-200. PubMed ID: 3158522
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of plasminogen activators (review of the literature)].
    Andreenko GV.
    Lab Delo; 1984 May 15; (1):6-11. PubMed ID: 6199577
    [No Abstract] [Full Text] [Related]

  • 11. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
    Maksimenko AV.
    Mol Biol (Mosk); 1995 May 15; 29(1):38-60. PubMed ID: 7723763
    [Abstract] [Full Text] [Related]

  • 12. Histochemistry and assay of plasminogen activator.
    Pandolfi M.
    Rev Eur Etud Clin Biol; 1972 Mar 15; 17(3):254-60. PubMed ID: 4262311
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Mechanism of thrombolytic enzymes].
    Matsuo O.
    Rinsho Ketsueki; 1993 Apr 15; 34(4):395-402. PubMed ID: 8510325
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 30; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.